Trial Profile

Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Nov 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fampridine (Primary)
Indications Multiple sclerosis
Focus Therapeutic Use

Most Recent Events

13 Sep 2014 Interim results (n = 17) presented at the 30th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
01 Nov 2012 Planned initiation date changed from 1 Mar 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov record.
13 Mar 2012 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com